Emerging Topics in Heart Failure: Heart Failure With Preserved and Mid-Range Ejection Fraction
- PMID: 33295463
- PMCID: PMC8452211
- DOI: 10.36660/abc.20201105
Emerging Topics in Heart Failure: Heart Failure With Preserved and Mid-Range Ejection Fraction
Conflict of interest statement
Miguel Morita Fernandes-Silva recebe honorários para palestras - Novartis.
Ricardo Mourilhe-Rocha recebe honorários para palestras – AstraZeneca, Bayer, Boehringer, Novartis, Servier, Takeda.
Flávio de Souza Brito recebe honorários para palestras - Novartis, Servier, AstraZeneca, Merck.
Antônio José Lagoeiro Jorge recebe honorários para palestras – Novartis.
Luiz Cláudio Danzmann recebe honorários para palestras – Novartis.
Figures
References
-
- 1. Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200. - PubMed
-
- 2. Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2020; 17:559-573. - PubMed
-
- 4. Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020; 22:391-412. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
